Cancer Biomarkers in Body Fluids

Cancer Biomarkers in Body Fluids

Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies.

Bibliographic Details
Format:	eBook
Language:	English
Published:	Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:	Medicine and Nursing Oncology anti-GD2 anti-PD-1 ASCT autoantibodies autoimmunity biomarker biomarkers bladder cancer blood biomarkers breast cancer breast cancer biomarkers cancer cancer biomarkers cancer development cancer pathogenesis cancer progression cancer susceptibility ceramide cerebrospinal fluid cfDNA circulating nucleosomes circulating tumor cells circulating tumor DNA colonoscopy ctDNA cytokines diagnosis diagnostic biomarkers diagnostics dinutuximab disease modelling DNA DNA methylation E7 oncoprotein early detection early diagnosis ELISA epigenetic biomarkers epigenetics exo-oncomiRNAS exosome exosomes extracellular vesicle extracellular vesicles fecal immunochemical test (FIT) flexible sigmoidoscopy gas chromatography (GC) GM-CSF headspace solid phase microextraction (HS-SPME) hereditary and familial pancreatic cancer HPV antibodies HPV DNA human papillomavirus IL-2 immune monitoring immunotherapy leptomeningeal metastasis linear discriminant analysis (LDA) lipid lipidomics liquid biopsy lung cancer machine learning mass spectrometry (MS) melanoma metabolic pathways metabolic signaling metabolism metabolomics micro-RNAs microRNA miRNA miRNAs molecular composition molecular pathways mRNA n/a NETs neuroblastoma next generation sequencing oropharyngeal squamous cell carcinoma outcome ovarian cancer patient stratification personalized medicine phospholipid PKC inhibitor plasma plasma metabolites plasmalogen plasminogen activator inhibitor-1 potentially druggable genes predictive biomarker primary breast cancer principal component analysis (PCA) principal component regression (PCR) prognosis prognostic biomarker prostate cancer proteins response rheumatoid factor RNA sequencing semen serum small non-coding RNA sncRNA somatic mutation profiling therapeutics treatment treatment de-escalation treatment decisions tumor load tumor recurrence TWEAK urine urine liquid biopsy urothelial cancer uveal melanoma volatile organic compounds (VOCs)
Online Access:	Open Access: DOAB: description of the publication Open Access: DOAB, download the publication

Similar Items

Increased Circulating MicroRNA-155 as a Potential Biomarker for Breast Cancer Screening: A Meta-Analysis
by: Faliang Wang, et al.
Published: (2014-05-01)

Serum Exosomes and Their miRNA Load—A Potential Biomarker of Lung Cancer
by: Mateusz Smolarz, et al.
Published: (2021-03-01)

Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors
by: Olaf Strømme, et al.
Published: (2021-06-01)

When Prostate Cancer Circulates in the Bloodstream
by: Virginie Vlaeminck-Guillem
Published: (2015-10-01)

Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
by: Katiusse Alves dos Santos, et al.
Published: (2021-12-01)

Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study
by: Michelle Davey, et al.
Published: (2020-11-01)

Comparison of Circulating Tumour DNA and Extracellular Vesicle DNA by Low-Pass Whole-Genome Sequencing Reveals Molecular Drivers of Disease in a Breast Cancer Patient
by: Olivia Ruhen, et al.
Published: (2021-12-01)

Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection
by: Xian Wang, et al.
Published: (2013-05-01)

Different miRNA expression profiles between human breast cancer turmors and serum
by: Jie eZhu, et al.
Published: (2014-05-01)

Plasma‐based microRNA signatures in early diagnosis of breast cancer
by: Xu Li, et al.
Published: (2020-05-01)

Advances in circular RNAs and their roles in breast Cancer
by: Xuehui Wang, et al.
Published: (2018-08-01)

Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer
by: Jin Wang, et al.
Published: (2014-02-01)

Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview
by: Riccardo Di Fiore, et al.
Published: (2021-04-01)

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
by: Jiayi Han, et al.
Published: (2020-09-01)

Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland
by: Yuliya A. Veryaskina, et al.
Published: (2020-05-01)

miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools
by: Leonardo J. Galvão-Lima, et al.
Published: (2021-02-01)

Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction
by: Emmanuel Gabriel, et al.
Published: (2018-08-01)

Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
by: Jen-Tai Lin, et al.
Published: (2021-04-01)

Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications
by: Reza Rahbarghazi, et al.
Published: (2019-07-01)

Exosomal MiRNAs in Pediatric Cancers
by: Angela Galardi, et al.
Published: (2019-09-01)

The role of circulating tumor DNA in patients with colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2016-10-01)

The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer
by: Esther Schwich, et al.
Published: (2018-03-01)

Circulating MicroRNAs in Cancer: Potential and Challenge
by: Mengying Cui, et al.
Published: (2019-07-01)

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease
by: Roxane Mari, et al.
Published: (2019-06-01)

MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
by: Simona Ruxandra Volovat, et al.
Published: (2020-11-01)

Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients
by: Motamedi M, et al.
Published: (2019-10-01)

Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer
by: Mousumi Majumder, et al.
Published: (2021-07-01)

Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer
by: Lei Wang, et al.
Published: (2021-09-01)

Circulating tumor DNA for personalized lung cancer monitoring
by: Clare Fiala, et al.
Published: (2017-08-01)

A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
by: Igor Brikun, et al.
Published: (2018-07-01)

Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer
by: Guilherme Rabinowits, et al.
Published: (2017-08-01)

Exosomal miRNAs as biomarkers for prostate cancer
by: Nina Pettersen Hessvik, et al.
Published: (2013-03-01)

Non-invasive Detection of Exosomal MicroRNAs via Tethered Cationic Lipoplex Nanoparticles (tCLN) Biochip for Lung Cancer Early Detection
by: Chang Liu, et al.
Published: (2020-03-01)

The Role of miRNAs and lncRNAs in Laryngeal Squamous Cell Carcinoma - a Mini-Review
by: Silva G. Kyurkchiyan, et al.
Published: (2020-06-01)

Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances
by: Catarina Lourenço, et al.
Published: (2021-03-01)

Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients
by: Bambi, F., et al.
Published: (2021)

Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
by: Edgars Endzeliņš, et al.
Published: (2017-11-01)

Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
by: Samuel Amintas, et al.
Published: (2021-02-01)

Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017
by: Aled Clayton, et al.
Published: (2018-12-01)

The Liquid Biopsy in the Management of Colorectal Cancer: An Overview
by: Marco Vacante, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_nfjeatbvjr507apacq4grackfq